baber/WOPTO huggingface dataset:
Patent NZ-541518-A (NZ)
Title: Solids separation and tank therefor
Inventor: COULTON RICHARD HENRY
IPC: B01D21/00
Filed: 2004-02-20
Abstract: A tank for separating solids from a suspension of the solids in liquid, the tank having an upper region containing a multiplicity of inclined plates (9) and a lower region for collecting solids settling from the upper region, the lower region having a bottom (3) which is approximately level or gently sloping, the tank further including an inlet (16) for introducing the suspension into the tank, a liquid outlet (19) and a plurality of solids outlets (22) at different fixed positions at the bottom (3) of the tank for removing solids separated in the tank.
Patent NZ-542737-A (NZ)
Title: Herbicidal mixtures comprising a safener
Inventor: WITSCHEL MATTHIAS
IPC: A01N43/80
Filed: 2004-03-10
Abstract: Disclosed is a herbicidal mixture comprising the herbicide topramezone or an environmentally compatible salt, with a safening effective amount of cloquinocet or one of its environmentally compatible salts, amides, esters, and hydrates.
Patent NZ-546248-A (NZ)
Title: Method and apparatus for replicating a database
Inventor: TARBELL JAMES SCOTT
Filed: 2001-10-01
Abstract: A method of replicating a database from a source computer system to a target computer system comprises: i) receiving journal entries from the source computer system; and ii) allocating program components to process journal entries and update the target database. A control program allocates tasks to program components and controls the program components substantially without program components interacting with one another. (62) Divided Out of 537170
Patent NZ-547046-A (NZ)
Title: 2-(1H-indolylsulfanyl)-benzyl amine derivatives as SSRI
Inventor: KEHLER JAN
IPC: C07D403/06
Filed: 2004-12-21
Abstract: The present disclosure relates to aniline derivatives of the general formula I with the substituents defined in the specification. Also disclosed is their use as serotonin reuptake inhibitors and preferably also norepinephrine reuptake inhibitors in the treatment of depression, anxiety, affective disorders, and pain disorders, attention deficit hyperactivity disorder (ADHD) and stress urinary incontinence.
Patent NZ-549823-A (NZ)
Title: 1,3,4-oxadiazol-2-ones as PPAR delta modulators
Inventor: CHANDROSS KAREN
IPC: A61P3/10
Filed: 2005-03-30
Abstract: Disclosed are 1,3,4-oxadiazol-2-ones of formula I, wherein ARYL is optionally substituted phenyl or pyridyl and the remaining substituents are as defined in the specification, and their pharmaceutically acceptable salts, stereoisomers, tautomers, and solvates. The compounds are modulators of PPAR-delta and therefore useful as pharmaceutical agents, especially for the treatment of demyelinating diseases and disorders of fatty acid metabolism and glucose utilization.
Patent NZ-550264-A (NZ)
Title: Applicator device for medicated materials
Inventor: SWICK PAUL B
IPC: A61M31/00
Filed: 2005-03-23
Abstract: A device for delivering a medicated product into a bodily cavity includes a barrel member having a dispensing end, a proximal end, which is positioned opposite the dispensing end, and a bore, which extends through the barrel member. The bore is sized and shaped so as to receive a medicated product therein and includes an opening formed in the dispensing end of the barrel member. The opening is sized and shaped so as to permit a medicated product received in the bore to be dispensed therethrough. The applicator is also provided with a plunger member movably extending through the bore of the barrel member for dispending a medicated product from the bore through the opening. The barrel member includes at least one substantially flexible section located between the dispending end and the proximal end such that the barrel member is bendable about the flexible section.
Patent NZ-551783-A (NZ)
Title: Membrane bioreactor
Inventor: TAYLOR ANTHONY PATRICK ANDREW
IPC: C12M3/00
Filed: 2005-05-18
Abstract: Disclosed is a membrane comprising a gel reinforced by a support, said membrane having opposing surfaces and a thickness between said surfaces whereby the gel communicates between said opposing surfaces.
Patent NZ-554571-A (NZ)
Title: Fastening tool having an operational lock
Inventor: CANNALIATO MICHAEL F
Filed: 2005-10-27
Abstract: A fastening tool having a trigger switch, an actuation member and a lockout switch. The two position trigger switch 158 - closed and open, executes a driver sequence in the closed position. The actuation switch has two positions. It moves the trigger switch into closed position in one position and moves away from the trigger switch in its second position. The lockout switch 170 which is connected to the actuation switch also has two positions - locked out and operational. In the first it prevents movement of the actuation member and in the second it does not
Patent NZ-554606-A (NZ)
Title: System and methods for the production of steam-pressed long fiber reconsolidated wood products
Inventor: JARCK WALTER
IPC: B27B1/00
Filed: 2005-09-21
Abstract: A system for the manufacture of steamed-pressed long fibre reconsolidated wood products 100, comprises a bonding agent application system 40 for applying bonding agent to a scrim log material mat, the bonding agent application system further comprising a bonding agent application roller press mechanism which compresses the scrim log material mat to further open any fissures or cracks within the scrim log material mat in order to aid in the uniform application of the bonding agent onto the scrim log material mat, a drying system 45 comprising a conveyor for transporting the scrim log material mat through the drying system 45, where the speed of the conveyor and the heat output by the drying system are regulated, an incremental mat cut-off system where the scrim log material mat is cut to a predetermined size to form a cut mat, a scrim log material mat lay-up system 50a, a scrim log material mat pre-press system for further formation of the scrim log material mat, the pre-press system 55 comprising heat conducting platens, and a steam press chamber 55 configured to receive the cut mat and release a predetermined volume of steam in order to cure the bonding agent that has been applied to the cut mat. The steam press chamber 55 further comprises a pressing mechanism configured to compress the cut mat to a predetermined thickness and density.
Patent NZ-554906-A (NZ)
Title: Lactam compounds and their use as pharmaceuticals
Inventor: YAO WENQING
IPC: A61K31/4015
Filed: 2005-11-09
Abstract: Disclosed are spirocyclic piperidinyl-lactam derivatives as represented by the general formula (I) or pharmaceutically acceptable salts thereof, wherein: Cy is optionally substituted aryl or heteroaryl moiety; Q is cyclohexyl substituted at the 4-position with at least one substituent selected from, OH, alkoxy, CN, alkyl, -O-heteroaryl, -alkyl-CN, COORa, C(O)NRcRd or NRcC(O)ORa; E is ethylene; R4, R5, R6, R7, R8, R9, R10 and R11 are each H; r is 1; and the remaining substituents are as defined herein. Also disclosed is the use of a pharmaceutical composition which comprises a compound as defined above for the manufacture of a medicament for treating obesity, diabetes, glucose intolerance, insulin resistance, hyperglycemia, hypertension, hyperlipidemia, cognitive impairment, depression, dementia, glaucoma, a cardiovascular disorder, osteoporosis, inflammation, renal disease, heart failure, atherosclerosis, arteriosclerosis, coronary artery disease, thrombosis, angina, peripheral vascular disease, vascular wall damage, stroke, dyslipidemia, hyperlipoproteinaemia, diabetic dyslipidemia, mixed dyslipidemia, hypercholesterolemia, hypertriglyceridemia, metabolic syndrome or general aldosterone-related target organ damage.
Patent NZ-555528-A (NZ)
Title: Improved cornice
Inventor: THOMPSON BILL
Filed: 2007-05-31
Abstract: Disclosed is a cornice having a longitudinally extending profile of constant cross section. The cornice has a substantially rectangular main body portion having opposed first and second faces. The first face is adapted to be concealed and the second face is adapted to be an exposed decorative surface, when the cornice is installed to a junction of a wall and ceiling. A stepped projection extends along one side of the main body portion of the cornice, such that the projection has opposed third and fourth faces offset from the main body portion. The cornice is adapted to be installed to the junction with the projection running adjacent to the wall. In this way, the cornice forms a recess between the wall and the main body portion. The cornice is composed of a substantially gypsum core with a paper lining and is made in a continuous process.
Patent NZ-564628-A (NZ)
Title: A cladding sheet with resistance to wind uplift
Inventor: SECCOMBE CAMPBELL JOHN
IPC: B21D13/04
Filed: 2006-06-21
Abstract: Disclosed is a cladding assembly that includes a number of concealed clips secured to an underlying structure and a number of cladding sheets that have enhanced uplift capacity. The cladding sheets are in side by side overlapping relationship and are retained on the underlying structure by the concealed clips. Each cladding sheet includes side formations on opposing sides of the sheet. The side formations engage complementary side formations on adjacent sheets and retain the sheets in side by side overlapping relationship. Each cladding sheet also includes at least one lengthwise extending pan and a lengthwise extending rib on each side of the pan. Each rib has a width of between 70% and 130% of the width of the pan. One side formation includes a re-entrant section that engages one concealed clip and a channel that opens inwardly of the sheet and is in a higher section of the one side formation. The other side formation forms one side of one rib and includes an in-turned lip that extends into the channel of the one side formation of an adjacent sheet. The other side of the one rib includes a re-entrant section that engages one concealed clip, and the engagement of this side of the one rib with the re-entrant section ensures that the in-turned lip extends into the channel and retains together the side formations and holds the adjacent sheets in overlapping relationship.
Patent NZ-570704-A (NZ)
Title: All natural multivitamin and multimineral dietary supplement formulations for enhanced absorption and biological utilization
Inventor: SINNOTT ROBERT A
IPC: A23L33/00
Filed: 2006-10-26
Abstract: Disclosed is a dietary supplement formulation comprising a standardized source of plant-derived minerals, wherein the mineral is in or about cellular structures and the standardized source of plant-derived minerals is standardized for the mineral; the dietary supplement formulation further comprising one or more natural vitamins or provitamins, and one or more plant extracts, wherein the supplement is compressed at a pressure greater than 2,000 psi and wherein the plant-derived minerals are selected from the group consisting of seedlings of Brassica napus, Brassica rapa, Brassica juncea, Medicago sativa, and Oryzae sativa seeds.
Patent NZ-577635-A (NZ)
Title: Pressure equalizing device for retaining aerosols when accessing a vial
Inventor: WHITLEY KENNETH W
IPC: A61J1/14
Filed: 2007-12-19
Abstract: A pressure-equalizing vial access device for retaining aerosols when accessing a vial having a pierceable seal located over an opening of the vial is disclosed. The vial access device comprises: a body portion (22), and a cannula (44) which has a medicament lumen and a vent lumen (62) separate from the medicament lumen. The cannula has a relatively sharp tip (46) to pierce the seal of the vial and a length selected so that the tip can be located within the vial. The body portion has a medicament port, a vent port and a rigid chamber (28). The rigid chamber has a filter and a volume control device (69). The medicament port is in fluid communication with the medicament lumen of the cannula, the medicament port is configured to receive a connector from a second container to allow liquid to be introduced into and removed from the vial. The vent port is in fluid communication with the vent lumen of the cannula. The vent port is separate from the medicament port and configured to allow passage of fluid to and from the vent lumen. The rigid chamber is located in fluid communication with the vent port and the vent lumen without being in fluid communication with the medicament port or medicament lumen. The rigid chamber has a pressure relief port (61) which is open to atmosphere and an equalizing port (57) connected to the vent port and vent lumen. The rigid chamber has rigid walls and a fixed internal volume. The filter is disposed at the equalizing port of the rigid chamber so that any fluid passing between the rigid chamber and the vent port must pass through the filter. The volume control device is located within and entirely confined by the rigid chamber and provides a sealed barrier between the equalizing port and the pressure relief port. The volume control device is freely movable between the equalizing port and the pressure relief port to vary the internal volume of the rigid chamber available to the equalizing port in response to pressure changes occurring in the vent lumen. Increases in pressure in the vial resulting from the introduction of liquid for reconstitution of vial contents are equalized by the volume control device moving away from the equalizing port to create a greater volume in the vent lumen/rigid chamber combination. Decreases in pressure in the vial resulting from aspiration of reconstituted liquid from the vial contents are equalized by the volume control device moving toward the equalizing port to create a lesser volume in the vent lumen/rigid chamber combination.
Patent NZ-578964-A (NZ)
Title: The use of nickel gibberllic acid and a nitrogen based butrient in agriculture and horticulture
Inventor: SPIERS ADRIAN
IPC: A01C21/00
Filed: 2010-08-09
Abstract: Disclosed is a method of treating a condition in a plant by applying a composition comprising nickel in a form capable of being taken up by the plant, gibberellic acid and at least one nitrogen-based nutrient acceptable to the plant, wherein the condition is selected from growth rate, nutrient uptake, plant health, rots, fungal diseases, necrotic spotting, fruit splitting and chlorophyll level; and the plant is selected from grasses and other pasture plants, pip fruits, stone fruits and grapes. Further disclosed is a composition for the treatment of a condition in a plant selected from grasses and other pasture plants, pip fruits, stone fruits and grapes, the composition comprising nickel in a form capable of being taken up by the plant, gibberellic acid and at least one nitrogen-based nutrient acceptable to the plant, wherein the condition is selected from growth rate, nutrient uptake, plant health, rots, fungal diseases, necrotic spotting, fruit splitting and chlorophyll level.
Patent NZ-580123-A (NZ)
Title: Using in-line sensing of oxygen levels in milk as a proxy to a somatic cell count to detect mastitis in cows
Inventor: BRAGGER JUDITH MARY
IPC: A01J5/013
Filed: 2010-11-01
Abstract: A method of determining whether a milking animal has mastitis is disclosed. It has been found that a decrease in oxygen levels in milk is related to an increase in the somatic cell count (SCC) levels, which is probably due to the neutrophils using oxygen and not the mammary secretary cells. Once the SCC level rises above a certain threshold (which is derived from oxygen readings) it is considered that most oxygen will be used up the neutrophils. Thus, by using this information and historical oxygen readings, it will be possible to determine the threshold at which an infection (mastitic condition) occurs. This is of considerable advantage from a management of herd treatment. The method has the steps of a) measuring on-line the level of oxygen within milk passing through the milking system at a point sufficiently close to the animal to reduce potential contamination of the milk with oxygen in the system; and b) determining the mastitic condition of the animal using historical data including at least one previously measured oxygen level in combination with the oxygen level measurement from a).
Patent NZ-588031-A (NZ)
Title: Bridged heterocycles as hiv integrase inhibitors
Inventor: BEAULIEU FRANCIS
IPC: A61K31/55
Filed: 2009-03-19
Abstract: Provided is a bicyclic pyrimidine with a bridging group X-Y-Z (as defined), of formula (I), with specified substituents. The compound is useful as a HIV integrase inhibitor and can be used to treat AIDS or HIV infection.
Patent NZ-588853-A (NZ)
Title: Compositions and methods for treating and diagnosing asthma
Inventor: ARRON JOSEPH R
IPC: C12Q1/68
Filed: 2009-03-31
Abstract: 588853 Disclosed is the use of an agent that binds IL-13 in the preparation of a medicament for the treatment of a patient having asthma, wherein the patient expresses elevated expression levels of POSTN gene. Further disclosed is a method of diagnosing an asthma subtype in a sample from an asthma patient comprising measuring the gene expression of POSTN, wherein elevated expression levels of POSTN as compared to healthy controls is indicative of the asthma subtype, wherein the asthma subtype is likely to respond to an agent that binds IL-13.
Patent NZ-589030-A (NZ)
Title: Method for producing a casein hydrolysate
Inventor: LYNGLEV GITTE B
IPC: A23J3/34
Filed: 2009-05-29
Abstract: Disclosed is a method for producing a casein hydrolysate, comprising: a) adding to a composition comprising from about 5% to about 25% casein an endopeptidase having at least 70% identity to SEQ ID NO: 1; and b) incubating so as to hydrolyse the casein. Also disclosed is the use of a casein hydrolysate produced by the method and the use of a casein hydrolysate in a food product.
Patent NZ-599643-A (NZ)
Title: Substituted N-aryl pyridinones as fibrotic inhibitors
Inventor: GANT THOMAS G
IPC: A61K31/4412
Filed: 2008-06-20
Abstract: ABSTRACT - 599643 The disclosure relates to substituted N-Aryl pyridinone fibrotic inhibitors and/or collagen infiltration modulators of formula (I), wherein the variables R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, and R11 are independently selected from the group consisting of hydrogen and deuterium; at least one of R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, and R11 independently has deuterium enrichment of no less than about 10%; and if R7, R8, R9, R10, and R11 are deuterium, then at least one of R1, R2, R3, R4, R5, and R6 is deuterium. Also disclosed is process of preparation, pharmaceutical compositions thereof, and methods of use of these substituted pyridinone-based fibrosis modulator and/or collagen infiltration modulator, preferably deuterated pirfenidone for treating fibrotic-mediated and the collagen-mediated disorder is selected from the group consisting of idiopathic pulmonary fibrosis, uterine fibroids, multiple sclerosis, renal fibrosis, diabetic kidney disease, endotoxin-induced liver injury after partial hepatectomy or hepatic ischemia, allograft injury after organ transplantation, cystic fibrosis, atrial fibrilation, neutropenia, scleroderma, dermatomyositis, cirrhosis, diffuse parenchymal lung disease, mediastinal fibrosis, tuberculosis, spleen fibrosis caused by sickle-cell anemia, and rheumatoid arthritis.
Patent NZ-600248-A (NZ)
Title: Method for producing low aluminium titanium-aluminium alloys
Inventor: HAIDAR JAWAD
IPC: C22B5/04
Filed: 2010-12-17
Abstract: Disclosed herein is a method for producing a titanium-aluminium alloy containing less than about 15wt.% aluminium. The method comprises a first step in which an amount of titanium subchlorides at or in excess of the stoichiometric amount required to produce the titanium-aluminium alloy are reduced by aluminium to form a reaction mixture comprising elemental titanium, and then a second step in which the reaction mixture comprising elemental titanium is heated to form the titanium-aluminium alloy. The reaction kinetics are controlled such that reactions resulting in the formation of titanium aluminides are minimised.
Patent NZ-600423-A (NZ)
Title: Building block and production thereof
Inventor: GRAY JOHN E
IPC: B28B7/16
Filed: 2010-11-10
Abstract: A one piece integrally moulded building block particularly for use in constructing a dry-stacking high performance masonry wall. The block aims to provide spaces for reinforcement. The block is comprised of parallel walls (102, 103) that are transversely spaced from each other so that adjacent walls have opposed inner surfaces and further comprised of at least one cross-wall (106-108) connecting said opposed inner surfaces of the parallel walls (102, 103). The cross-walls (106-108) incorporate intermediate their end regions a recess (116) in their upper surface (115a, 115b). The end regions of the cross-walls (106-108) are compacted wholly below the upper surfaces (102a-105a) of the parallel walls (102, 103).
Patent NZ-602054-A (NZ)
Title: Anti-nerve growth factor (ngf) antibody compositions
Inventor: SAEDLER RAINER
IPC: C07K16/28
Filed: 2011-03-16
Abstract: Disclosed is a pharmaceutical composition comprising: a. anti-nerve growth factor (NGF) antibody, or antigen binding fragment thereof; b. a histidine buffer at a concentration of about 5 to about 60 mM and c. polysorbate 80 at a concentration of about 0.01 v/v% to about 0.1 v/v%; wherein the pH of the composition is about 5 to 6.
Patent NZ-603870-A (NZ)
Title: A stator frame for a submerged linear generator, a use thereof and a method for manufacturing a linear generator
Inventor: AXELSSON FREDRIK
IPC: H02K35/02
Filed: 2010-05-28
Abstract: A stator frame (12) for a submerged linear generator particularly for use in a wave power generator is disclosed. The stator frame (12) includes a cylindrical tube of metal with mounting means (13, 14, 15, 16) for mounting stator packets to the inside wall of the tube. When the linear generator is assembled, the tube (12) also forms an outer circumferential wall of the linear generator.
Patent NZ-608987-A (NZ)
Title: Injection moulded unupholstered plastic chair
Inventor: WELSH GREGORY BRENT
IPC: A47C7/02
Filed: 2013-04-03
Abstract: 608987 A seat (31) for use in relation to chairs for the avoidance or amelioration of ischial burstis is disclosed. The seat is injection moulded from a plastic material, is un-upholstered and is not provided with any cushion or padding. A pair of spaced apart concavities (37, 38), which do not deform in use, are located in the upper surface of the un-upholstered injection moulded seat. The spacing between the concavities corresponds to the spacing between the ischial tuberosities of a user intended to sit on the seat. The seat surface is further provided with a thin vertical extent to provide some flexibility and is spaced from any supporting frame by a distance (see 36, figure 11) sufficient to allow the seat surface to deflect slightly when a user sits on the seat.
Patent NZ-609924-A (NZ)
Title: Porphyrin treatment of neurodegenerative diseases
Inventor: PATEL MANISHA
IPC: C07D487/22
Filed: 2011-10-06
Abstract: Provided are porphyrin compounds, of general formula (I) or (II), where the variables are as described in the specification. The compounds may be useful in the treatment of neurodegenerative diseases, such as Parkinson’s disease.
Patent NZ-610862-A (NZ)
Title: Optimized synthesis of pure, non-polymorphic, crystalline bile acids with defined particle size
Inventor: WILHELM RUDOLF
IPC: C07J9/00
Filed: 2011-11-30
Abstract: NZ 610862 Disclosed is a chemically pure polymorph of Nor-UDCA or Bis-nor-UDCA, or of a pharmaceutically acceptable salt thereof, wherein the total amount of chemical impurities is less than 0.5%, and at least 60% of the polymorph particles have a size < 10 µ.